ADVANCE infectious diseases pharmacy through collaboration, research and education and LEAD antimicrobial stewardship to OPTIMIZE the care of patients with infections in every practice setting

Featured News

  • 06 May 2014 3:14 PM | Christopher McCoy

    WHO reports the accessible information on national ABR surveillance

    and on ABR data for a set of common pathogenic bacteria, in order to present an analysis of the global situation as it appeared in 2013 in a summary document.

  • 08 Apr 2014 4:16 PM | Christopher McCoy
    The 2014 annual meeting will take place in conjunction with ICAAC, on Friday, September 5th at the Mandarin Oriental Hotel in Washington DC. The business meeting and CE programming is planned to begin at noon with a reception to follow at 6:30pm.  More information about registration to come soon.
  • 27 Mar 2014 4:48 PM | Christopher McCoy

    The Board of Directors of the Society of Infectious Diseases Pharmacists (SIDP) is

    pleased to announce the availability of funding from Cubist Pharmaceuticals, Inc. to support TWO Antimicrobial Stewardship/Infectious Diseases Pharmacotherapy Residencies or Fellowships for the period of July 2014 through June 2015.

    The intent of this funding is to foster the development of advanced training opportunities for pharmacists committed to the practice area and/or research of antimicrobial stewardship and infectious diseases.  See the attached RFP with hyperlinks.

  • 17 Mar 2014 7:54 PM | Christopher McCoy

    Data presented at CROI in Boston was recently published in Science detailing the use of a depot injection of a new integrase inhibitor that protected macaques from simian/human immunodeficiency virus infection for at least 6 weeks.  PrEP is currently limited to Truvada with ongoing studies of vaginal rings implanted with NNRTI's and topical agents including tenofovir gel. The Truvada prevention study results were notable for lesser protection with low medication adherence.  A depot approach would alleviate this potential.  The studies remain limited to animals.

  • 17 Mar 2014 3:59 PM | Christopher McCoy

    Gubbins PO, Klepser ME, Dering-Anderson AM, Bauer K, Darin KM, Klepser S, Matthias KR, Scarsi K. Point of care testing for infectious diseases: Opportunities, barriers and considerations in community pharmacy. J Am Pharm Assoc 2014;54(2):163–171.


    “CLIA-waived point of care (POC) tests for infectious diseases represent a unique opportunity for community pharmacists to expand their patient care services while also benefitting patients and developing a public health role of the profession. This work was produced by members of the Society’s Task Force on Rapid Diagnostic Tests. They reviewed the literature and researched state pharmacy laws and determined that pharmacists in many states could apply for CLIA waivers for POC testing  and offer testing for Group A streptococcal pharyngitis, HIV, and hepatitis C virus. In addition they highlight barriers to implementing such services in community pharmacies and point out that while barriers to implementing such services exist, they are not insurmountable.”


    For a link to the abstract, click here.

  • 13 Mar 2014 4:00 PM | Christopher McCoy
    An assessment endorsed by SHEA, ASHP and SIDP on antimicrobial use and stewardship capabilities has been organized and open for response. The goal of this endeavor is to assess current processes, associated capabilities, and resource limitations within U.S. hospitals. To best describe the available infrastructure and potential challenges an on a national level, all facilities are highly encouraged to respond. Use the following link to respond.
  • 13 Mar 2014 7:48 AM | Christopher McCoy

    California is looking for acute care hospitals within the state to volunteer information about their antimicrobial stewarship program (ASP). The state is interested in hearing from all hospitals regardless of their level of ASP development in an effort to help inform other facilities how to make their programs more robust.  See the link for the questionnaire.

  • 04 Mar 2014 5:09 PM | Christopher McCoy
    Today, the CDC published a "Vital Signs" report based on an analysis of the national administrative database (MarketScan Hospital Drug Database) and CDC's Emerging Infections Program (EIP) data with NHSN utilization data that supports the need for stewardship programs in hospitals.  The authors conclude that antibiotics are overprescribed and a thoughtful 30% reduction in use could result in a 26% reduction in CDI in addition to other benefits. For a full look at the report, visit the online publication.
  • 03 Mar 2014 5:11 PM | Christopher McCoy
    There are few legendary figures in Infectious Diseases practice and I had the distinct honor of working directly with one.  I was saddened to attend the funeral of Dr. Robert Moellering in the suburbs of Boston this past Saturday.  The institution where I worked with Dr. Moellering released this very detailed In Memoriam statement.  I know some of you had an opportunity to collaborate with him and many were able to attend one of his presentations at a national meeting.
  • 21 Feb 2014 8:30 AM | Christopher McCoy
    Did you know that you can review draft versions of government agency documents including those administered by the CDC at  The site allows anyone to review and comment on these proposed documents for a period of time.  Beyond greenhouse gas emission and endangered species classifications, you may be interested in CDC proposed guidelines like the draft guidelines for the prevention of surgical site infections.  These are available via search of the site or more easily here.  You can download a pdf of the draft and then comment by the deadline which in this case is Feb 28th.

Membership gives you more

  • Access exclusive opportunities
  • Connect with colleagues
  • Attend networking events


Society of Infectious Diseases Pharmacists • 403 W. Saint Charles, Suite B, Lombard, IL 60148
(331) 248-7888
Proudly Managed by Affinity Strategies

Powered by Wild Apricot Membership Software